SCOTTS MIRACLE-GRO CO SMG
NYSE · stock · Agricultural Chemicals · website · IPO 1995-12-29
SCOTTS MIRACLE-GRO CO financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.6B | $3.6B | $3.9B | $4.9B | $4.1B | $3.2B | $2.7B | $2.6B | $2.5B |
| Gross profit | $1.0B | $850.5M | $657.3M | $872.9M | $1.5B | $1.3B | $1.0B | $864.6M | $972.6M | $900.3M |
| R&D expense | $34.8M | $34.6M | $35.7M | $45.3M | $45.4M | $39.7M | $39.6M | $42.5M | $39.9M | $36.0M |
| SG&A expense | $603.4M | $559.0M | $551.3M | $613.0M | $743.5M | $757.8M | $601.3M | $540.1M | $550.9M | $518.0M |
| Operating income | $358.6M | $208.8M | -$174.4M | -$434.0M | $723.0M | $585.2M | $409.6M | $198.9M | $433.4M | $447.6M |
| Interest expense | $128.8M | $158.8M | $178.1M | $118.1M | $78.9M | $79.6M | $101.8M | $86.4M | $76.1M | $62.9M |
| Income tax | $76.5M | $11.3M | -$73.2M | -$120.6M | $159.8M | $123.7M | $144.9M | -$11.9M | $116.6M | $137.6M |
| Net income | $145.2M | -$34.9M | -$380.1M | -$437.5M | $512.5M | $387.4M | $460.7M | $63.7M | $218.3M | $315.3M |
| EPS (diluted) | $2.47 | $-0.61 | $-6.79 | $-7.88 | $8.96 | $6.81 | $8.18 | $1.12 | $3.63 | $5.09 |
| Operating cash flow | $371.3M | $667.5M | $531.0M | -$129.0M | $271.5M | $558.0M | $226.8M | $342.5M | $363.2M | $244.0M |
| Free cash flow | $273.9M | $583.5M | $438.2M | -$242.5M | $164.6M | $495.3M | $184.4M | $274.3M | $293.6M | $185.7M |
| Cash & equivalents | $32.8M | $71.6M | $31.9M | $86.8M | $244.1M | $16.6M | $18.8M | $33.9M | $120.5M | $28.6M |
| Inventory | $542.7M | $587.5M | $880.3M | $1.3B | $1.1B | $621.9M | $540.3M | $481.4M | $407.5M | $394.7M |
| Total assets | $2.7B | $2.9B | $3.4B | $4.3B | $4.8B | $3.4B | $3.0B | $3.1B | $2.7B | $2.8B |
| Total liabilities | $3.1B | $3.3B | $3.7B | $4.1B | $3.8B | $2.7B | $2.3B | $2.7B | $2.1B | $2.0B |
| Shareholders' equity | -$357.5M | -$390.6M | -$267.3M | $147.7M | $1.0B | $702.9M | $723.2M | $359.6M | $661.7M | $734.3M |
Growth · year-over-year · Revenue CAGR 3.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -3.9% | +0.0% | -9.5% | -20.3% | +19.2% | +30.9% | +18.5% | +0.8% | +5.4% | -16.9% |
| Net income growth | — | — | — | -185.4% | +32.3% | -15.9% | +623.2% | -70.8% | -30.8% | +97.3% |
| EPS growth | — | — | — | -187.9% | +31.6% | -16.7% | +630.4% | -69.1% | -28.7% | +98.1% |
| Free cash flow growth | -53.1% | +33.2% | — | -247.3% | -66.8% | +168.6% | -32.8% | -6.6% | +58.1% | +0.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.